Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

5 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

5(55.6%)

N/A

4(44.4%)

9Total

Phase 4(5)

N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06671990Phase 4Not Yet Recruiting

The CardioMEMS Vericiguat Heart Failure Trial

Role: lead

NCT05284955Phase 4Unknown

Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (SAINTS B)

Role: lead

NCT02658136Not ApplicableCompleted

Right Ventricular Function and Exercise Capacity in Patients With Continuous-flow Left Ventricular Assist Devices

Role: lead

NCT03844516Not ApplicableUnknown

Pacing in Left Ventricular Assist Device Recipients

Role: lead

NCT03576677Phase 4Unknown

Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure

Role: lead

NCT03405831Phase 4Unknown

Effect of Ivabradine on Exercise Capacity After Heart Transplantation

Role: lead

NCT01748331Not ApplicableUnknown

The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia

Role: lead

NCT01748006Unknown

The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure

Role: lead

NCT01974557Not ApplicableCompleted

The Effect of Age on the Hemodynamic Response During Rest and Exercise in Healthy Humans

Role: lead

NCT01752543Phase 4Completed

Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients

Role: lead

All 10 trials loaded